QS Investors’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

QS Investors’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-15,300	Closed	-$1.48M	–	1679
2019 Q3	$1.48M	Hold	15,300	–	–	0.02%	655
2019 Q2	$1.57M	Buy	15,300 +14,000	+1,077%	+$1.51M	0.02%	665
2019 Q1	$149K	Hold	1,300	–	–	﹤0.01%	1300
2018 Q4	$51K	Hold	1,300	–	–	﹤0.01%	1452
2018 Q3	$71K	Hold	1,300	–	–	﹤0.01%	1449
2018 Q2	$108K	Buy	+1,300	New	+$100K	﹤0.01%	1390

QS Investors's ONCE Position: Q4 2019 in Review

QS Investors sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 15,300 shares — an estimated $1.48M sold.

QS Investors first reported a position in ONCE in Q2 2018 and held it in 6 quarters. The position peaked at $1.57M in Q2 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

QS Investors reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
QS Investors sold 15,300 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $1.48M.
QS Investors first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2018 and held it in 6 quarters.
QS Investors's Spark Therapeutics, Inc. Common Stock position peaked at $1.57M in Q2 2019.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on QS Investors's 13F filing for Q4 2019, filed 14 Feb 2020.